Global law firm Norton Rose Fulbright has advised Australian founded medicinal cannabis company, Althea Group Holdings Limited, on its $19.65m initial public offering (“IPO”) and listing on the Australian Securities Exchange (“ASX”).
September 26, 2018
Global law firm Norton Rose Fulbright has advised Sunrise Medical Group on its acquisition of multi-national wheelchair designer and manufacturer Magic Mobility.
August 02, 2018
Global law firm Norton Rose Fulbright has advised the Hammon Family on their successful tender to operate the iconic Sydney Harbour Bridge’s tourism climb business under a 20 year concession arrangement with Roads and Maritime Services (RMS). The Hammon Family fought off competing bids from other high profile attractions operators to win this landmark tender.
June 17, 2018
A cross-border team from global law firm Norton Rose Fulbright is advising US-based medtech giant Varian Medical Systems, Inc. on its proposed AU$1.58bn acquisition of all of the issued share capital of ASX-listed life sciences company Sirtex Medical Limited, currently the largest takeover deal announced in Australia for 2018.
February 08, 2018
Global law firm Norton Rose Fulbright today announced the launch of “Parker”, the first Australian law firm chatbot to respond on privacy law, powered by artificial intelligence.
December 13, 2017
Global law firm Norton Rose Fulbright has acted as the Australian legal advisers to the Walter and Eliza Hall Institute of Medical Research on the partial monetisation of a royalty due for sales of venetoclax, a new anti-cancer drug.
August 21, 2017
Washington D.C. partner Rick Robinson and Melbourne partner Bernard O’Shea discuss the US Sunshine Act.
November 04, 2015